PURANDHAR TUMMALA's Insider Trades & SAST Disclosures
PURANDHAR TUMMALA's most recent trade in Natco Pharma Ltd. was a Disposal of 4,000 Equity Shares done at an average price of Rs. 9682.5 . Disclosure was reported to the exchange on Jan. 4, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for PURANDHAR TUMMALA in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natco Pharma | PURANDHAR TUMMALA | Employee | Disposal | 04 Jan 2021 | 4,000 | 258,835 (0.14%) | 0.00% | 9682.5 | 38,730,036 | 31 Dec 2020 01 Jan 2021 |
Insider Trading | Equity Shares | Market Sale |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.